302 related articles for article (PubMed ID: 19569972)
1. Misclassification of first-line antiretroviral treatment failure based on immunological monitoring of HIV infection in resource-limited settings.
Kantor R; Diero L; Delong A; Kamle L; Muyonga S; Mambo F; Walumbe E; Emonyi W; Chan P; Carter EJ; Hogan J; Buziba N
Clin Infect Dis; 2009 Aug; 49(3):454-62. PubMed ID: 19569972
[TBL] [Abstract][Full Text] [Related]
2. Treatment failure and drug resistance in HIV-positive patients on tenofovir-based first-line antiretroviral therapy in western Kenya.
Brooks K; Diero L; DeLong A; Balamane M; Reitsma M; Kemboi E; Orido M; Emonyi W; Coetzer M; Hogan J; Kantor R
J Int AIDS Soc; 2016; 19(1):20798. PubMed ID: 27231099
[TBL] [Abstract][Full Text] [Related]
3. Misdiagnosis of HIV treatment failure based on clinical and immunological criteria in Eastern and Central Kenya.
Joram SL; Paul G; Moses K; Stanley B; Isaac M; Allan G; Tom M; Lilian K; Mildred M
BMC Infect Dis; 2017 Jun; 17(1):383. PubMed ID: 28577527
[TBL] [Abstract][Full Text] [Related]
4. Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda.
Ssempijja V; Nakigozi G; Chang L; Gray R; Wawer M; Ndyanabo A; Kasule J; Serwadda D; Castelnuovo B; Hoog AV; Reynolds SJ
BMC Infect Dis; 2017 Aug; 17(1):582. PubMed ID: 28830382
[TBL] [Abstract][Full Text] [Related]
5. CD4 count-based failure criteria combined with viral load monitoring may trigger worse switch decisions than viral load monitoring alone.
Hoffmann CJ; Maritz J; van Zyl GU
Trop Med Int Health; 2016 Feb; 21(2):219-23. PubMed ID: 26584666
[TBL] [Abstract][Full Text] [Related]
6. Optimal monitoring strategies for guiding when to switch first-line antiretroviral therapy regimens for treatment failure in adults and adolescents living with HIV in low-resource settings.
Chang LW; Harris J; Humphreys E
Cochrane Database Syst Rev; 2010 Apr; (4):CD008494. PubMed ID: 20393969
[TBL] [Abstract][Full Text] [Related]
7. A single CD4 test with 250 cells/mm3 threshold predicts viral suppression in HIV-infected adults failing first-line therapy by clinical criteria.
Gilks CF; Walker AS; Munderi P; Kityo C; Reid A; Katabira E; Goodall RL; Grosskurth H; Mugyenyi P; Hakim J; Gibb DM;
PLoS One; 2013; 8(2):e57580. PubMed ID: 23437399
[TBL] [Abstract][Full Text] [Related]
8. Adoption of routine virologic testing and predictors of virologic failure among HIV-infected children on antiretroviral treatment in western Kenya.
Kadima J; Patterson E; Mburu M; Blat C; Nyanduko M; Bukusi EA; Cohen C; Oyaro P; Abuogi L
PLoS One; 2018; 13(11):e0200242. PubMed ID: 30412576
[TBL] [Abstract][Full Text] [Related]
9. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
van Oosterhout JJ; Brown L; Weigel R; Kumwenda JJ; Mzinganjira D; Saukila N; Mhango B; Hartung T; Phiri S; Hosseinipour MC
Trop Med Int Health; 2009 Aug; 14(8):856-61. PubMed ID: 19552661
[TBL] [Abstract][Full Text] [Related]
11. Switching HIV treatment in adults based on CD4 count versus viral load monitoring: a randomized, non-inferiority trial in Thailand.
Jourdain G; Le Cœur S; Ngo-Giang-Huong N; Traisathit P; Cressey TR; Fregonese F; Leurent B; Collins IJ; Techapornroong M; Banchongkit S; Buranabanjasatean S; Halue G; Nilmanat A; Luekamlung N; Klinbuayaem V; Chutanunta A; Kantipong P; Bowonwatanuwong C; Lertkoonalak R; Leenasirimakul P; Tansuphasawasdikul S; Sang-A-Gad P; Pathipvanich P; Thongbuaban S; Wittayapraparat P; Eiamsirikit N; Buranawanitchakorn Y; Yutthakasemsunt N; Winiyakul N; Decker L; Barbier S; Koetsawang S; Sirirungsi W; McIntosh K; Thanprasertsuk S; Lallemant M;
PLoS Med; 2013 Aug; 10(8):e1001494. PubMed ID: 23940461
[TBL] [Abstract][Full Text] [Related]
12. Utility of CD4 cell counts for early prediction of virological failure during antiretroviral therapy in a resource-limited setting.
Badri M; Lawn SD; Wood R
BMC Infect Dis; 2008 Jul; 8():89. PubMed ID: 18601727
[TBL] [Abstract][Full Text] [Related]
13. Switching to second-line antiretroviral therapy in resource-limited settings: comparison of programmes with and without viral load monitoring.
; Keiser O; Tweya H; Boulle A; Braitstein P; Schecter M; Brinkhof MW; Dabis F; Tuboi S; Sprinz E; Pujades-Rodriguez M; Calmy A; Kumarasamy N; Nash D; Jahn A; MacPhail P; Lüthy R; Wood R; Egger M
AIDS; 2009 Sep; 23(14):1867-74. PubMed ID: 19531928
[TBL] [Abstract][Full Text] [Related]
14. Immunologic criteria are poor predictors of virologic outcome: implications for HIV treatment monitoring in resource-limited settings.
Rawizza HE; Chaplin B; Meloni ST; Eisen G; Rao T; Sankalé JL; Dieng-Sarr A; Agbaji O; Onwujekwe DI; Gashau W; Nkado R; Ekong E; Okonkwo P; Murphy RL; Kanki PJ;
Clin Infect Dis; 2011 Dec; 53(12):1283-90. PubMed ID: 22080121
[TBL] [Abstract][Full Text] [Related]
15. A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi.
Ongubo DM; Lim R; Tweya H; Stanley CC; Tembo P; Broadhurst R; Gugsa S; Ngongondo M; Speight C; Heller T; Phiri S; Hosseinipour MC
BMC Infect Dis; 2017 Jul; 17(1):461. PubMed ID: 28673254
[TBL] [Abstract][Full Text] [Related]
16. Trends in CD4 and viral load testing 2005 to 2018: multi-cohort study of people living with HIV in Southern Africa.
Zaniewski E; Dao Ostinelli CH; Chammartin F; Maxwell N; Davies MA; Euvrard J; van Dijk J; Bosomprah S; Phiri S; Tanser F; Sipambo N; Muhairwe J; Fatti G; Prozesky H; Wood R; Ford N; Fox MP; Egger M
J Int AIDS Soc; 2020 Jul; 23(7):e25546. PubMed ID: 32640106
[TBL] [Abstract][Full Text] [Related]
17. A Markov model for the effects of virological failure on HIV/AIDS progression in tuberculosis co-infected patients receiving antiretroviral therapy in a rural clinic in northern South Africa.
Shoko C; Chikobvu D; Bessong PO
S Afr Med J; 2020 Mar; 110(4):313-319. PubMed ID: 32657744
[TBL] [Abstract][Full Text] [Related]
18. Immunological failure of first-line and switch to second-line antiretroviral therapy among HIV-infected persons in Tanzania: analysis of routinely collected national data.
Vanobberghen FM; Kilama B; Wringe A; Ramadhani A; Zaba B; Mmbando D; Todd J
Trop Med Int Health; 2015 Jul; 20(7):880-92. PubMed ID: 25779383
[TBL] [Abstract][Full Text] [Related]
19. Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
Rewari BB; Bachani D; Rajasekaran S; Deshpande A; Chan PL; Srikantiah P
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):610-4. PubMed ID: 20890211
[TBL] [Abstract][Full Text] [Related]
20. Performance of immunological response in predicting virological failure.
Ingole N; Mehta P; Pazare A; Paranjpe S; Sarkate P
AIDS Res Hum Retroviruses; 2013 Mar; 29(3):541-6. PubMed ID: 23137294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
